openPR Logo
Press release

AI for Drug Discovery Market Size, Strategy, Business Outlook to 2027 - Atomwise, Insilico Medicine, BIOAGE, Numerate, NuMedii, Envisagenics, Cloud, BenevolentAI, twoXAR, Exscientia

11-14-2019 12:09 PM CET | Health & Medicine

Press release from: Premium Market Insights

AI for Drug Discovery Market

AI for Drug Discovery Market

Drug discovery is the preliminary step in the process of a novel drug identification and its therapeutic target. Artificial intelligence (AI) is commonly used in the healthcare industry for drug discovery. Artificial intelligence technology has the ability to recognize drug targets, and play a significant role in drug design, discovery, identification and screening of molecules instantly and effectively. Drug discovery or new drug target are being estimated based on potency, bioavailability, efficacy, and toxicity.

The global AI for drug discovery market is segmented on the basis of drug type, technology, application, and end user. On the basis of drug type, the market is classified as small molecule and large molecules. Based on technology, the market is classified as deep learning and machine learning. Based on application, the market is classified as metabolic disease, cardiovascular disease, oncology, neurodegenerative diseases, and others. On the basis of end user, the market is classified as pharmaceutical & biotechnological companies, academic & research institutes, and others.

Get Sample PDF For More Professional And Technical Insights at:
https://www.premiummarketinsights.com/sample/TIP00012580

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global AI for drug discovery market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The AI for drug discovery market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting AI for drug discovery market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend.

The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the AI for drug discovery market in these regions.

Table of Content:
1 Introduction
1.1 Scope of Study

2 Key Takeaways

3 AI for Drug Discovery Market Landscape
3.1 Market Overview
3.2 Market Segmentation
3.3 PEST Analysis

4 AI for Drug Discovery Market - Key Industry Dynamics
4.1 Key Market Drivers
4.2 Key Market Restraints
4.3 Key Market Opportunities
4.4 Future Trends
4.5 Impact Analysis

5 AI for Drug Discovery Market Analysis- Global
5.1 Global AI for Drug Discovery Market Overview
5.2 Global AI for Drug Discovery Market Forecasts and Analysis
5.3 Market Positioning/Market Share
5.4 Performance of Key Players
5.5 Expert Opinions AI for Drug Discovery Market

Name: Sameer Joshi
Email: sales@premiummarketinsights.com
Organization: Premium Market Insights
Phone: +1-646-491-9876

Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release AI for Drug Discovery Market Size, Strategy, Business Outlook to 2027 - Atomwise, Insilico Medicine, BIOAGE, Numerate, NuMedii, Envisagenics, Cloud, BenevolentAI, twoXAR, Exscientia here

News-ID: 1867378 • Views:

More Releases from Premium Market Insights

Hyperpigmentation Disorder Treatment Market Analysis, Reviews, and Study Reports …
"The global hyperpigmentation disorder treatment market is expected to reach US$ 6.67 billion in 2022 to US$ 11.78 billion by 2030; it is estimated to register a CAGR of 7.4% from 2022 to 2030." According to The Premium Market Insights "Hyperpigmentation Disorder Treatment Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Hyperpigmentation Disorder Treatment Market Research Reports
Oncology Biosimilars Market Global Research and Clinical Survey Report 2023 to 2031
Oncology Biosimilars Market Global Research and Clinical Survey Report 2023 to 2 …
"The oncology biosimilars market was valued at US$ 9.46 billion in 2023 and is anticipated to reach US$ 24.71 billion by 2031; it is projected to register a CAGR of 12.8% from 2023 to 2031." According to The Premium Market Insights "Oncology Biosimilars Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Oncology Biosimilars Market Research Reports offers
Mesotherapy Market Developments, Competitive Analysis, and Forecasts 2022 to 2030
Mesotherapy Market Developments, Competitive Analysis, and Forecasts 2022 to 203 …
"The mesotherapy market size is expected to grow from US$ 561.20 million in 2022 to US$ 1,148.60 million by 2030; it is anticipated to record a CAGR of 9.4% from 2022 to 2030." According to The Premium Market Insights "Mesotherapy Market" report, discusses various factors driving or restraining the market, which will help the future market to grow with promising CAGR. The Mesotherapy Market Research Reports offers an extensive collection of
Spinal Cord Stimulator Device Market Size, Share, Global Trends, Major Key Playe …
The Spinal Cord Stimulator Device Market is expected to grow from US$ 2,779.91 million in 2022 to US$ 4,967.52 million by 2030; it is anticipated to record a CAGR of 7.5% from 2022 to 2030. A spinal cord stimulation device is an implanted device that relieves pain by transmitting low-level electrical signals directly into the spinal cord. The stimulator is mostly used after nonsurgical pain treatments fail to provide sufficient relief.

All 5 Releases


More Releases for Drug

Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions. Alcohol abuse and drug
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.  Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Introduction to Hepatitis Disease 1.1 Prologue 1.1.1 History of Hepatitis 1.1.2 Causes of Hepatitis Disease 1.2 Types of Viruses which are Responsible for Hepatitis Disease 2. Global Prevalence of Hepatitis Infection 3. Available Drug Classes for Hepatitis Disease Treatment 3.1 Interferon Alfa Therapy 3.2 Protease Inhibitors Therapy 3.3 Polymerase
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents 1. Indispensable Advent of Microcapsules 1.1 Trajectory of Microencapsulation 1.2 Why and wherefores for Microencapsulation 2. Characterization of Microcapsules 2.1 Composition of Microcapsules 2.2 Parameters Influencing Microcapsules 3. Engineering Technology of Microcapsules 3.1 Physical Manufacturing Technologies 3.2 Physicochemical and Chemical Technologies 4. Applicability of Microcapsules 4.1 Microcapsules in Pharmaceuticals 4.2 Microcapsules in Nutraceuticals
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June. The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug